Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.2K
Protein Networks02:26

Protein Networks

4.3K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

781
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
781

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual plasticity of Hippolyte inermis Leach (Crustacea, Decapoda): Gene expression of vitellogenin and insulin-like androgenic gland hormone.

Animal reproduction science·2026
Same author

Genomic insights into the prevalence and genetic diversity of <i>Salmonella</i> in chicken eggs in Saudi Arabia.

Frontiers in microbiology·2026
Same author

Enhancing the Diagnosis of Behçet's Disease Using Machine Learning: A Comparative Study on Clinical Data From Saudi Arabia.

International journal of telemedicine and applications·2026
Same author

Genomic and epidemiological insights into the emergence and dominance of MRSA clones in Riyadh's healthcare facilities.

Scientific reports·2026
Same author

Hybrid quantum neural network models for fruit quality assessment.

PloS one·2025
Same author

Genomic diversity and antimicrobial resistance of <i>Staphylococcus aureus</i> in Saudi Arabia: a nationwide study using whole-genome sequencing.

Microbial genomics·2025

Related Experiment Video

Updated: Nov 21, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.3K

DTiGEMS+: drug-target interaction prediction using graph embedding, graph mining, and similarity-based techniques.

Maha A Thafar1,2, Rawan S Olayan1,3, Haitham Ashoor1,3

  • 1Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.

Journal of Cheminformatics
|January 12, 2021
PubMed
Summary

DTiGEMS+ enhances drug discovery by accurately predicting drug-target interactions using graph embedding and mining. This computational method significantly reduces false positives, improving drug repositioning efforts.

Keywords:
BioinformaticsCheminformaticsDrug repositioningDrug–target interactionGraph embeddingHeterogenous networkMachine learningSimilarity integrationSimilarity-based

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

907

Related Experiment Videos

Last Updated: Nov 21, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.3K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

907

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Accurate in silico prediction of drug-target interactions is crucial for sustainable drug development and drug repositioning.
  • Existing computational methods often yield high false-positive rates, necessitating improved prediction accuracy.

Purpose of the Study:

  • To introduce DTiGEMS+, a novel computational method for predicting drug-target interactions.
  • To address the limitations of current methods by reducing false-positive rates in drug-target interaction prediction.

Main Methods:

  • DTiGEMS+ utilizes Graph Embedding, graph Mining, and Similarity-based techniques to predict drug-target interactions.
  • It models interactions as a link prediction problem in a heterogeneous network, integrating drug-drug and target-target similarity graphs.
  • The method combines graph embeddings, graph mining, and machine learning, incorporating a similarity selection and fusion algorithm.

Main Results:

  • DTiGEMS+ demonstrated superior prediction performance across four benchmark datasets.
  • Achieved the highest average AUPR (0.92) among state-of-the-art in silico methods.
  • Reduced the error rate by 33.3% compared to the second-best performing model.

Conclusions:

  • DTiGEMS+ offers a significant advancement in predicting drug-target interactions.
  • The method's improved accuracy supports more efficient and reliable drug repositioning and development.
  • DTiGEMS+ provides a robust computational tool for identifying novel drug-target relationships.